Published in Medical Letter on the CDC and FDA, December 12th, 2004
The standard, which will help identify testing errors, is for a commonly used procedure that identifies a genetic predisposition to thrombosis, or blood clots, a potentially life-threatening condition.
"Establishment of the first international standard for a genetic test is an important milestone," said David...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA